[1] 邬迪,王志伟.脱细胞技术及其在肝脏组织工程中的应用[J].江苏医药,2014,40(18):2176-2179.
[2] 游辅宇,高毅.生物三维打印技术在肝组织工程的应用与展望[J].重庆医学,2018,47(31):4056-4058.
[3] 曾敏,傅恭博,鄢和新.基于脱细胞技术的肝脏组织工程研究进展[J].肝脏,2017,22(2):165-167.
[4] 刘鹏,向俊西,郑幸龙,等.基于脾脏脱细胞支架构建组织工程肝脏的体内植入策略[J].南方医科大学学报,2018,38(6):698-703.
[5] 王鑫英,周伦,陈亚慧.人造肝脏研究进展[J].器官移植,2017,8(6): 480-482.
[6] 杨扬,王励.肝脏组织工程研究进展[J].器官移植,2017,8(5): 337-343.
[7] 胡泉,李颖,周瑾,等.肝组织工程的研究进展与展望[J].生物医学工程研究,2009,28(1):79-82.
[8] 张婷,池慧,欧阳昭连.基于专利分析的手术机器人竞争态势研究[J].中国医学装备,2018,15(7):119-123.
[9] 林鑫,肖宇锋,张佳维,等.基于专利计量分析的国际抗高血压药物研究[J].中国新药杂志,2019,28(15):1797-1802.
[10] 房梦雅,王青华,徐来,等.基于德温特专利数据库近10年组织工程支架、技术、假体领域的专利分析[J].中国组织工程研究,2019, 23(18):2894-2899.
[11] 陈娟,武一丹,张婷,等.中国组程织工基础研究实力:基于文献计量学的分析[J].中国组织工程研究,2019,23(26):4175-4180.
[12] 张婷,陈娟,欧阳昭连,等.组织工程与再生医学领域的专利竞争态势[J].中国组织工程研究,2019,23(34):5479-5485.
[13] 张婷,陈娟,池慧,等.基于专利分析的医疗器械领域技术竞争态势研究[J].中国医疗设备,2019,34(5):107-113.
[14] 汪庆,李军莲,朱钦磊,等.基于专利分析的基因组编辑技术国际竞争态势研究分析[J].中华医学图书情报杂志,2019,28(2):12-18.
[15] 石亮,张善杰,刘晓琴.专利视角下的全球深海采矿技术发展态势分析与对策建议[J].情报探索,2019,(4):41-51.
[16] CHUN HJ, PARK CH, KWON IK, et al. Cutting-Edge Enabling Technologies for Regenerative Medicine. Singapore: Springer. 2018.
[17] WANG X, AO Q, TIAN X, et al. Gelatin-Based Hydrogels for Organ 3D Bioprinting. Polymers. 2017;9(12):401.
[18] WANG X, LIU C. Fibrin Hydrogels for Endothelialized Liver Tissue Engineering with a Predesigned Vascular Network. Polymers. 2018;10(10):1048.
[19] WANG X, YAN Y, PAN Y, et al. Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue Eng. 2006;12(1):83-90.
[20] ZHOU Q, LI L, LI J. Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications. Liver Int. 2015;35(3):687-694.
[21] HU C, LI L. In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases. Stem Cells Int. 2015; 2015:1-11.
[22] WANG LY, LIU LP, GE JY, et al. A Multiple-Cell Microenvironment in a 3-Dimensional System Enhances Direct Cellular Reprogramming Into Hepatic Organoids. Transplant Proc. 2018;50(9):2864-2867.
[23] FOX DB, COOK JL, ARNOCZKY SP, et al. Fibrochondrogenesis of free intraarticular small intestinal submucosa scaffolds. Tissue eng. 2004;10(1-2):129-137.
[24] AGARWAL T, SUBRAMANIAN B, MAITI TK. Liver Tissue Engineering: Challenges and Opportunities. ACS Biomater Sci Eng. 2019;5(9):4167-4182.
[25] RODRÍGUEZ-SALVADOR M, RIO-BELVER RM, GARECHANA-ANACABE G. Scientometric and patentometric analyses to determine the knowledge landscape in innovative technologies: the case of 3D bioprinting. PLoS One. 2017; 12(6):e180375.
[26] 罗涛.基于3D打印技术构建类肝组织及体内外活性分析[D].杭州:浙江省医学科学院,2018.
[27] LI J, XING F, CHEN F, et al. Functional 3D Human Liver Bud Assembled from MSC-Derived Multiple Liver Cell Lineages. Cell Transplant. 2019;28(5):510-521.
[28] ZHANG L, GUAN Z, YE J, et al. Research progress in liver tissue engineering. Biomed Mater Eng. 2017;28(s1): S113-S119.
[29] 丁宇峰.中美专利质量控制措施比较与启示[J].理论与改革, 2016,(4):160-165.
[30] 何甜田.中国专利质量问题研究[D].济南:山东大学,2014.
|